BFRI

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

Dollar change 0.00
Percentage change 0.00	%

Peers: ATNM CLDX DVAX GERN IMUX MREO PLX RIGL TGTX TNXP

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.27	Insider Own	19.91%	Shs Outstand	6.53M	Perf Week	1.59%
Market Cap	7.83M	Forward P/E	-	EPS next Y	-0.85	Insider Trans	0.00%	Shs Float	6.21M	Perf Month	16.09%
Income	-12.84M	PEG	-	EPS next Q	-0.03	Inst Own	17.53%	Short Float	8.54%	Perf Quarter	-18.55%
Sales	35.36M	P/S	0.22	EPS this Y	76.69%	Inst Trans	-26.09%	Short Ratio	0.18	Perf Half Y	10.99%
Book/sh	0.85	P/B	1.19	EPS next Y	71.99%	ROA	-48.79%	Short Interest	0.53M	Perf Year	-65.88%
Cash/sh	0.37	P/C	2.72	EPS next 5Y	-	ROE	-390.90%	52W Range	0.61 - 3.90	Perf YTD	-63.54%
Dividend Est.	-	P/FCF	-	EPS past 5Y	7.90%	ROI	-219.29%	52W High	-74.10%	Beta	0.37
Dividend TTM	-	Quick Ratio	0.94	Sales past 5Y	9.41%	Gross Margin	45.35%	52W Low	65.57%	ATR (14)	0.13
Dividend Ex-Date	-	Current Ratio	1.53	EPS Y/Y TTM	88.42%	Oper. Margin	-54.76%	RSI (14)	51.26	Volatility	8.27% 13.54%
Employees	85	Debt/Eq	0.18	Sales Y/Y TTM	5.17%	Profit Margin	-36.30%	Recom	1.00	Target Price	11.50
Option/Short	No / Yes	LT Debt/Eq	0.06	EPS Q/Q	78.84%	Payout	-	Rel Volume	0.03	Prev Close	1.01
Sales Surprise	-9.88%	EPS Surprise	-17.37%	Sales Q/Q	1.30%	Earnings	Nov 13 AMC	Avg Volume	2.91M	Price	1.01
SMA20	-1.85%	SMA50	7.77%	SMA200	-13.59%	Trades		Volume	83,591	Change	0.00%

Dec-23-24 09:30AM	Biofrontera Inc. Announces 100 RhodoLED XL Machines Now Placed in US Market (GlobeNewswire)
Dec-03-24 11:00AM	Biofrontera Inc. to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference (ACCESSWIRE) -6.39%
Nov-22-24 09:10AM	Biofrontera Inc. Closes a $4.2 Million Senior Secured Convertible Note (GlobeNewswire) +14.62%
Nov-13-24 05:15PM	Biofrontera Inc. Reports Third Quarter and Nine-Month 2024 Financial Results and Provides Business Update (GlobeNewswire) -11.54% -15.38%
Nov-01-24 11:55AM	Biofrontera Inc. to Report Third Quarter Financial Results on November 13, 2024 (ACCESSWIRE) -11.38%
10:32AM	Loading…
Oct-31-24 10:32AM	Biofrontera Inc. Announces Highly Significant Results In Phase 3 Study Of Ameluz -Photodynamic Therapy (PDT) Regarding The Treatment Of Superficial Basal Cell Carcinoma (sBCC) (GlobeNewswire) +31.71%
Oct-14-24 10:30AM	Biofrontera Inc. Announces Database Lock Of Phase 3 Study Of Ameluz -Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC) (GlobeNewswire)
Oct-07-24 08:45AM	FDA Approves Use of Up To Three Tubes of Biofrontera Inc.'s Ameluz (aminolevulinic acid HCI) Topical Gel, 10% In One Treatment (GlobeNewswire) -9.48%
Sep-25-24 10:45AM	Biofrontera to Present at the 3rd Annual ROTH Healthcare Opportunities Conference (ACCESSWIRE)
Aug-14-24 04:30PM	Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update (GlobeNewswire) -7.32%
Aug-09-24 10:00AM	Biofrontera Inc. to Report Second Quarter Financial Results on August 14, 2024 (ACCESSWIRE)
Jun-24-24 08:30AM	Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED XL Lamp (GlobeNewswire) -5.35%
May-15-24 09:53PM	BFRI Stock Earnings: Biofrontera Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace) -6.20% -9.92%
04:45PM	Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update (ACCESSWIRE)
May-06-24 10:30AM	Biofrontera Inc. to Report First Quarter 2024 Financial Results on May 15, 2024 (ACCESSWIRE)
08:50AM	Loading…
May-03-24 08:50AM	Biofrontera Announces Achievement of Two Milestones Associated with Series B-3 Convertible Preferred Stock Warrants (ACCESSWIRE)
Mar-26-24 04:30PM	Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals (ACCESSWIRE) -5.45%
Mar-19-24 09:22AM	Biofrontera Inc. (NASDAQ:BFRI) Q4 2023 Earnings Call Transcript (Insider Monkey) -6.35%
Mar-15-24 09:52PM	BFRI Stock Earnings: Biofrontera Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace) -11.43% -18.71%
08:25PM	CORRECTION: Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update (ACCESSWIRE)
06:10PM	Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update (ACCESSWIRE)
Mar-08-24 09:00AM	Biofrontera Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 15, 2024 (ACCESSWIRE)
Feb-23-24 08:40AM	Biofrontera Inc. Announces Closing of Private Placement of up to $16.0 Million Priced at Market per Nasdaq Rules (ACCESSWIRE) -7.54%
Feb-20-24 08:10AM	Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG (ACCESSWIRE) +53.44%
08:05AM	Biofrontera Inc. Announces Private Placement of Up To $16.0 Million Priced at Market per Nasdaq Rules (ACCESSWIRE)
Feb-05-24 05:15PM	Biofrontera Inc. Announces FDA Filing of Supplemental New Drug Application for Ameluz(R) to Permit Up to Three Tubes Per Use (ACCESSWIRE) -5.00%
Feb-02-24 08:07AM	Why Is Biofrontera (BFRI) Stock Down Today? (InvestorPlace) -31.09%
Jan-11-24 04:15PM	Biofrontera Inc. Announces Preliminary Revenues for the Fourth Quarter and Full Year 2023 (ACCESSWIRE)
Nov-22-23 09:55AM	Biofrontera Inc. (BFRI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? (Zacks)
Nov-11-23 12:05PM	Biofrontera Inc. (NASDAQ:BFRI) Q3 2023 Earnings Call Transcript (Insider Monkey)
05:10PM	Loading…
Nov-09-23 05:10PM	Biofrontera Inc. Reports Third Quarter 2023 Financial Results and Provides a Business Update (ACCESSWIRE) -5.78%
12:00PM	Biofrontera Inc. (BFRI) Upgraded to Buy: Here's What You Should Know (Zacks)
Nov-03-23 08:30AM	Biofrontera Inc. to Report Third Quarter 2023 Financial Results on November 9 and Hold Conference Call on November 10 (ACCESSWIRE) -9.11%
Oct-31-23 08:01AM	Biofrontera Inc. Announces $4.5 Million Registered Direct Offering Priced At-the-market Under NASDAQ Rules (ACCESSWIRE) +23.68%
Oct-10-23 09:00AM	Biofrontera Inc. Receives FDA Approval for New Formulation of Ameluz(R) (ACCESSWIRE) -8.57%
Oct-05-23 09:00AM	Biofrontera Inc. to Participate in the Roth MKM 2023 Healthcare Opportunities Conference and the 43rd Annual Fall Clinical Dermatology Conference (ACCESSWIRE)
Oct-04-23 08:30AM	Biofrontera Inc. Announces Preliminary Third Quarter Revenues (ACCESSWIRE)
Aug-29-23 08:00AM	Biofrontera Inc. Appoints Samantha Widdicombe to Support Commercial Relationships with Strategic Customer Accounts (ACCESSWIRE)
Aug-28-23 08:00AM	Biofrontera Inc. Announces Positive Results from Phase 1 Safety Study Evaluating Photodynamic Therapy with Three Tubes of Ameluz(R) (ACCESSWIRE)
Aug-11-23 08:25AM	Biofrontera Inc. (BFRI) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
07:00AM	Biofrontera Inc. Reports Second Quarter 2023 Financial Results and Provides a Business Update (ACCESSWIRE)
Aug-10-23 08:30AM	Biofrontera Inc. Announces Last Patient Enrolled in Phase 3 Clinical Study Evaluating Ameluz(R)-PDT for the Treatment of Basal Cell Carcinoma (ACCESSWIRE)
Aug-04-23 08:30AM	Biofrontera Inc. to Report Second Quarter Financial Results on August 11, 2023 (ACCESSWIRE)
Jul-13-23 09:00AM	Biofrontera Inc. Announces Preliminary Second Quarter Revenues are Up 26% to 31% (ACCESSWIRE)
Jul-12-23 08:00AM	Biofrontera Inc. Appoints Dr. Heikki Lanckriet to its Board of Directors (ACCESSWIRE)
Jul-03-23 11:42AM	Breakeven On The Horizon For Biofrontera Inc. (NASDAQ:BFRI) (Simply Wall St.)
09:15AM	Biofrontera Inc. Announces 1-for-20 Reverse Stock Split (ACCESSWIRE)
Jun-12-23 09:00AM	Biofrontera Inc. Sponsors The Sun Bus, Delivering Free Mobile Skin Cancer Screenings Across the U.S. (ACCESSWIRE)
Jun-01-23 09:15AM	Biofrontera Inc. Begins Development of a Portable Photodynamic Therapy Lamp for Use with Ameluz(R)-PDT (ACCESSWIRE)
May-30-23 09:00AM	Biofrontera Inc. Names Founder and Executive Chairman Hermann Luebbert as Chief Executive Officer (ACCESSWIRE)
May-15-23 09:50AM	Biofrontera Inc. Announces U.S. Patent Issued for Photodynamic Therapy Protocol with Reduced Side Effects (ACCESSWIRE)
May-12-23 09:55AM	Biofrontera Inc. (BFRI) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -28.63%
08:12AM	BFRI Stock Earnings: Biofrontera Misses EPS, Revenue Estimates (InvestorPlace)
07:30AM	Biofrontera Inc. Reports First Quarter 2023 Financial Results and Provides a Business Update (ACCESSWIRE)
07:00AM	Biofrontera Inc. Announces Resignation of CEO (ACCESSWIRE)
May-11-23 09:00AM	Biofrontera Inc. Announces New Secured Line of Credit up to $6.5 Million (ACCESSWIRE) -5.22%
May-09-23 09:00AM	Biofrontera Collaborates with The Skin Cancer Foundation to Raise Awareness of Skin Cancer Prevention (ACCESSWIRE)
Apr-28-23 10:00AM	Biofrontera Inc. to Report First Quarter 2023 Financial Results on May 12, 2023 (ACCESSWIRE)
Apr-26-23 10:00AM	Biofrontera Inc. Announces Last Patient Out in Phase I Study to Evaluate Safety and Tolerability in Treating Actinic Keratosis Using 3 Tubes of Ameluz(R) (ACCESSWIRE) -5.34%
Mar-27-23 08:00AM	Biofrontera Inc. Makes Transformative Investment in Its' Dermatology Salesforce (ACCESSWIRE)
Mar-17-23 01:30PM	Biofrontera Inc. to Attend 2023 American Academy of Dermatology Annual Meeting (ACCESSWIRE)
Mar-11-23 07:50AM	Biofrontera Inc. (NASDAQ:BFRI) Analysts Just Slashed Next Year's Estimates (Simply Wall St.)
Mar-10-23 02:25AM	Biofrontera Inc. (NASDAQ:BFRI) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-09-23 08:20AM	CORRECTING AND REPLACING: Biofrontera Inc. Reports Fourth Quarter and Record Full-year 2022 Financial Results (ACCESSWIRE) -10.24%
Mar-08-23 04:03PM	Biofrontera Inc. Reports Fourth Quarter and Record Full-year 2022 Financial Results (ACCESSWIRE)
Mar-02-23 09:00AM	Biofrontera, Inc. to Present at the 35th Annual ROTH Conference on March 13, 2023 (ACCESSWIRE) -7.22%
Feb-22-23 08:00AM	Biofrontera Inc. to Report Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023 (ACCESSWIRE)
Feb-15-23 08:00AM	Biofrontera, Inc. to Present at Third Annual Winter Wonderland Best Ideas Virtual Investor Conference on February 21st 24th, 2023 (ACCESSWIRE)
Jan-24-23 10:27AM	Breakeven On The Horizon For Biofrontera Inc. (NASDAQ:BFRI) (Simply Wall St.)
Jan-09-23 01:00PM	Biofrontera Inc. Announces First Patient Dosed in Pivotal Phase 3 Clinical Study Evaluating Ameluz(R)-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and Trunk (ACCESSWIRE) +12.22%
08:00AM	Biofrontera Inc. Announces Preliminary Revenues for the Fourth Quarter and Full Year 2022 (ACCESSWIRE)
Dec-16-22 08:30AM	Biofrontera Inc. Announces Voting Results from 2022 Annual Meeting of Stockholders (GlobeNewswire) -11.22%
Dec-06-22 10:18AM	11 Best German Stocks to Buy Now (Insider Monkey)
Nov-30-22 02:08PM	Biofrontera Inc. to Participate in Benchmarks 11th Annual Discovery One-on-One Investor Conference (GlobeNewswire)
Nov-28-22 11:05AM	BIOFRONTERA INC. TO PARTICIPATE IN RENMARKS VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, NOVEMBER 30, MONDAY, DECEMBER 5, FRIDAY, DECEMBER 9, AND MONDAY, DECEMBER 19 2022 (GlobeNewswire) +5.06%
Nov-21-22 08:48AM	Biofrontera to Launch Phase 3 Clinical Study Evaluating Ameluz®-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and Trunk (GlobeNewswire)
Nov-16-22 06:39AM	Biofrontera Third Quarter 2022 Earnings: EPS Beats Expectations (Simply Wall St.)
Nov-14-22 10:05AM	Biofrontera Inc. (BFRI) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
08:45AM	Biofrontera Inc. Reports Third Quarter 2022 Financial Results and Provides a Business Update (GlobeNewswire)
Nov-10-22 11:52AM	Biofrontera Inc. to Report Third Quarter Financial Results on November 14, 2022 (GlobeNewswire) +11.31%
Nov-08-22 04:45PM	Biofrontera Inc. Fully Exercises Recently Acquired Options to Purchase Shares of Biofrontera AG (GlobeNewswire) -7.02% -8.21%
Oct-31-22 08:55AM	Biofrontera Inc. Enters into Agreements to Purchase Options of Biofrontera AG (GlobeNewswire)
Oct-24-22 07:45AM	Biofrontera Inc. Names Fred Leffler as Chief Financial Officer (GlobeNewswire)
Oct-20-22 11:40AM	Biofrontera Inc. to Present at the LD Micro Main Event XV Investor Conference (GlobeNewswire)
Oct-18-22 10:30AM	Biofrontera Inc. to Sponsor the 2022 Fall Clinical Dermatology Conference (GlobeNewswire)
Oct-14-22 08:40AM	Biofrontera Inc. Adopts Limited Duration Shareholder Rights Plan (GlobeNewswire) +5.22%
Oct-12-22 02:00PM	BIOFRONTERA INC. TO PARTICIPATE IN RENMARKS VIRTUAL NON-DEAL ROADSHOW SERIES ON FRIDAY OCTOBER 14, AND TUESDAY OCTOBER 18, 2022 (GlobeNewswire)
Oct-05-22 05:00PM	Biofrontera Inc. Announces Preliminary Product Revenues for the Third Quarter of 2022 (GlobeNewswire)
Sep-29-22 10:04AM	Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference (GlobeNewswire) +5.24%
Sep-27-22 06:21AM	Here's Why Biofrontera (NASDAQ:BFRI) Must Use Its Cash Wisely (Simply Wall St.)
Sep-26-22 08:30AM	Biofrontera Inc.s Marketing Campaign and Website for Ameluz Won 2022 PM360 Trailblazer Awards (GlobeNewswire)
Sep-13-22 08:30AM	Biofrontera Inc. Names Gerard DiGirolamo as National Sales Director (GlobeNewswire)
Sep-06-22 10:31AM	Biofrontera Inc. Announces Notice of Allowance for Nanoemulsion Composition-of-Matter U.S. Patent (GlobeNewswire) +5.88%
Aug-18-22 11:05AM	Biofrontera Inc.s Leslie Hopkins Named PM360 Trailblazer 2022 Brand Champion for Dermatology (GlobeNewswire) -5.04%
Aug-17-22 08:02AM	Biofrontera Inc. (NASDAQ:BFRI): Are Analysts Optimistic? (Simply Wall St.)
Aug-12-22 08:33AM	Biofrontera Inc. Reports Second Quarter 2022 Financial Results and Provides a Business Update (GlobeNewswire)
Aug-04-22 08:30AM	Biofrontera Inc. to Report Second Quarter Financial Results on August 12, 2022 (GlobeNewswire)
Aug-01-22 11:00AM	Biofrontera Inc. Announces Patent in Australia for Novel Illumination Protocols Granted to Biofrontera Bioscience GmbH (GlobeNewswire) +6.99%
Jul-27-22 08:45AM	Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Private Placement (GlobeNewswire) -12.20%
Jul-12-22 08:00AM	Biofrontera Inc. Announces Preliminary Product Revenues for the Second Quarter of 2022 (GlobeNewswire) +7.61%

Biofrontera, Inc. is a biopharmaceutical company, which engages in the commercialization of pharmaceutical products. It specializes in the treatment of dermatological conditions, caused primarily by exposure to sunlight that results in sun damage to the skin. The company is focused on the treatment of actinic keratosis and markets a topical antibiotic for treatment of impetigo. Its products include Ameluz and Xepi, its two prescription drugs, and BF-RhodoLED, a lamp used with Ameluz, for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company was founded on March 3, 2015 and is headquartered in Woburn, MA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Biofrontera Inc

Upgrade your FINVIZ experience